HALO Trading Analysis - 09/23/2026 11:11 AM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for HALO Therapeutics include:

• HALO Therapeutics announces positive topline results from Phase 2 trial of its lead asset, HALO-301, in patients with non-small cell lung cancer.
• The company reports a significant increase in its cash reserves, providing a strong financial position to advance its clinical pipeline.
• HALO Therapeutics completes enrollment in its Phase 3 trial of HALO-302 for the treatment of patients with certain types of solid tumors.

These headlines suggest a positive outlook for HALO Therapeutics, with potential catalysts for future growth.

Fundamental Analysis:

Revenue and Profit Margins: HALO's total revenue is $1,663,738,000 with a profit margin of 24.86%. The gross margin is 82.42%, operating margin is 35.90%, and net margin is 24.86%.

Earnings Per Share (EPS): The trailing EPS is $3.42.

Valuation: The trailing P/E ratio is 33.66, and the price-to-book ratio is 195.60.

Debt/Equity and ROE: The debt-to-equity ratio is 16.96, and the return on equity (ROE) is 2.88%.

Cash Flow: The operating cash flow is $818,595,000.

Overall, HALO's fundamentals indicate a strong revenue position with healthy profit margins, but a relatively high P/E ratio and significant debt levels.

Current Market Position:

Current Price: $114.16

Recent Price Action: The stock has shown an uptrend, with a recent high of $116.84 and a low of $98.13 over the past 30 days.

Support and Resistance: Key support levels are around $110, and resistance levels are around $115.

Technical Analysis:

SMA Trends: The 5-day SMA is $112.57, the 20-day SMA is $108.98, and the 50-day SMA is $98.26. The stock is currently above all three SMAs, indicating a bullish trend.

RSI: The RSI is 61.63, indicating a slightly overbought condition but still within a bullish range.

MACD: The MACD is 3.7, suggesting a bullish signal.

Bollinger Bands: The stock is currently near the upper band, indicating a potential overbought condition.

True Sentiment Analysis (Delta 40-60 Options):

Options Flow Sentiment: The overall options flow sentiment is balanced, with a call dollar volume of $2,400 and a put dollar volume of $3,140.

Call vs Put: The call percentage is 43.3%, and the put percentage is 56.7%, indicating a slightly bearish bias in options trading.

Key Price Levels:

Support: Around $110.00, Resistance: around $115.00.

25-Day Price Forecast:

HALO is projected for $118.00 to $122.00 based on current technical trends, momentum, and indicators.

The forecast is based on the current uptrend, RSI momentum, MACD signals, and recent volatility (ATR).

Defined Risk Strategy Recommendations:

Based on the price forecast of $118.00 to $122.00, consider the following defined risk strategies:

• Bull Call Spread: Buy the $115.0 call and sell the $120.0 call.
• Iron Condor: Sell the $110.0 put, buy the $105.0 put, sell the $115.0 call, and buy the $120.0 call.
• Protective Put: Buy the $110.0 put.

These strategies align with the projected price range and provide defined risk exposure.

Risk Factors:

• Technical warning signs or weaknesses: Overbought conditions.
• Sentiment divergences from price action: Slightly bearish bias in options trading.
• Volatility and ATR considerations: Recent increase in volatility.

These factors could invalidate the thesis if they persist or worsen.

Summary & Conviction Level:

Overall Bias: Bullish

Conviction Level: High

One-line Trade Idea: Buy HALO with a target of $120.00 and a stop loss at $110.00.